监测超声检测肝细胞癌:聚焦肝脏方案采用US LI-RADS技术指南与通用全腹部超声方案的比较
这项单中心前瞻性研究将465例肝细胞癌高危患者随机分配至聚焦肝脏超声组(A组,230例)或全腹部超声组(B组,235例),A组结节检出率10%(23个结节)显著高于B组1.3%(3个结节)(p<.001)。A组5例、B组1例经完整诊断流程确诊肝细胞癌。作者结论认为基于聚焦肝脏超声的筛查方案提高了高危人群肝结节检出率。
要点
- 聚焦肝脏超声按US LI-RADS技术指南操作,高危人群结节检出率10% vs 全腹部超声1.3%(p<.001)。
- A组230例中检出23个结节,B组235例中检出3个结节,组间性别、年龄、病因、MELD评分及甲胎蛋白无显著差异。
- A组5例、B组1例经完整诊断流程确诊肝细胞癌。
核心结论
- 采用基于聚焦肝脏超声的肝细胞癌筛查方案可提高高危个体肝结节检出率。
研究设计与样本
- IRB批准的单中心前瞻性研究,2016年6月至2019年9月纳入肝细胞癌高危患者,随机分配至A组(聚焦肝脏超声)或B组(全腹部超声)。
- 共纳入465例,A组230例、B组235例;20名腹部超声经验相近的检查者随机分配至两组各10名,专做本组检查。
- A组按US LI-RADS技术指南行聚焦肝脏超声,B组行完整上腹部扫描;组间结节检出频率采用Fisher精确检验比较。
关键影像表现/征象
- A组230例中检出23个肝结节(占样本10%),B组235例中检出3个结节(占1.3%),A组结节检出频率显著高于B组(p<.001)。
- A组5例、B组1例经完整诊断流程确诊肝细胞癌。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Focused US examinations of the liver in the routine hepatocellular carcinoma (HCC) screening reduce the time spent on evaluating other structures deemed irrelevant to the clinical setting. It is still unknown, however, if such a strategy may additionally improve the frequency of nodules detection. We aimed to assess the impact of an HCC surveillance program in high-risk patients by means of targeted liver US following LI-RADS technical guidelines in comparison to a complete upper abdominal scan.
METHODS: In this IRB-approved, single-center, prospective study, patients at high-risk for HCC enrolled from 06/2016 to 09/2019 were randomly assigned to 1 of the 2 institutional protocols: Group A (targeted liver US) or Group B (complete upper abdominal scan). Twenty examiners with similar experience in abdominal US were randomly assigned to perform the examinations exclusively in 1 of the groups (10 in each group). Frequency of hepatic nodules between groups was compared by using Fisher's exact test.
RESULTS: Four hundred and sixty-five patients were enrolled, with no significant differences in both groups regarding sex, age, etiology of liver disease, MELD scores, and alpha-fetoprotein levels. A significantly higher frequency of nodules detection was found in Group A (230 patients; 23 nodules detected; 10% of the sample) in comparison to Group B (235 patients; 3 nodules; 1.3% of the sample) (p <.001). Five patients in Group A and 1 in Group B were positive for HCC after full diagnostic work-up.
CONCLUSION: Adopting an HCC screening program based on targeted liver US improved the detection of hepatic nodules among high-risk individuals.
引用
- da Silva PH, Gomes MM, de Matos CAL, et al. HCC Detection on Surveillance US: Comparing Focused Liver Protocol Using US LI-RADS Technical Guidelines to a General Complete Abdominal US Protocol. J Ultrasound Med. 2021. PMID: 33463734. doi:10.1002/jum.15637
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。